Journal article
Severe Plasmodium falciparum malaria: targets and mechanisms associated with protection in Kenyan children.
- Abstract:
- Severe malaria (SM) is a life-threatening complication of infection with Plasmodium falciparum. Epidemiological observations have long indicated that immunity against SM is acquired relatively rapidly, but prospective studies to investigate its immunological basis are logistically challenging and have rarely been undertaken. We investigated the merozoite targets and antibody-mediated mechanisms associated with protection against SM in Kenyan children aged 0 to 2 years. We designed a unique prospective matched case-control study of well-characterized SM clinical phenotypes nested within a longitudinal birth cohort of children (n = 5,949) monitored over the first 2 years of life. We quantified immunological parameters in sera collected before the SM event in cases and their individually matched controls to evaluate the prospective odds of developing SM in the first 2 years of life. Anti-AMA1 antibodies were associated with a significant reduction in the odds of developing SM (odds ratio [OR] = 0.37; 95% confidence interval [CI] = 0.15 to 0.90; P = 0.029) after adjustment for responses to all other merozoite antigens tested, while those against MSP-2, MSP-3, Plasmodium falciparum Rh2 [PfRh2], MSP-119, and the infected red blood cell surface antigens were not. The combined ability of total IgG to inhibit parasite growth and mediate the release of reactive oxygen species from neutrophils was associated with a marked reduction in the odds of developing SM (OR = 0.07; 95% CI = 0.006 to 0.82; P = 0.03). Assays of these two functional mechanisms were poorly correlated (Spearman rank correlation coefficient [rs] = 0.12; P = 0.07). Our data provide epidemiological evidence that multiple antibody-dependent mechanisms contribute to protective immunity via distinct targets whose identification could accelerate the development of vaccines to protect against SM.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.7MB, Terms of use)
-
(Preview, Version of record, pdf, 1.6MB, Terms of use)
-
- Publisher copy:
- 10.1128/IAI.01120-15
Authors
+ Wellcome Trust
More from this funder
- Funding agency for:
- Murungi, L
- Osier, F
- Grant:
- 084538/Z/07/B
- MR/L00450X/1
+ Medical Research Council
More from this funder
- Funding agency for:
- Osier, F
- Draper, S
- Grant:
- MR/L00450X/1
- G1000527
- Publisher:
- American Society for Microbiology
- Journal:
- Infection and Immunity More from this journal
- Pages:
- IAI.01120-15-IAI.01120-15
- Publication date:
- 2016-01-19
- Acceptance date:
- 2016-01-14
- DOI:
- EISSN:
-
1098-5522
- ISSN:
-
0019-9567
- Language:
-
English
- Pubs id:
-
pubs:598034
- UUID:
-
uuid:638a8097-c509-492d-ad8d-37cdb12929db
- Local pid:
-
pubs:598034
- Source identifiers:
-
598034
- Deposit date:
-
2016-03-29
Terms of use
- Copyright holder:
- Murungi et al
- Copyright date:
- 2016
- Notes:
- Copyright © 2016 Murungi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record